| Market Capitalization (Millions $) |
37 |
| Shares
Outstanding (Millions) |
34 |
| Employees |
9 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-33 |
| Cash Flow (TTM) (Millions $) |
-4 |
| Capital Exp. (TTM) (Millions $) |
0 |
Reviva Pharmaceuticals Holdings Inc
Reviva Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company that is headquartered in San Francisco, California, United States. The company is focused on developing best-in-class small molecule therapeutics that target GPCRs (G Protein-Coupled Receptors), which are membrane-bound proteins that are involved in several physiological processes in the human body.
Reviva is dedicated to the discovery, development, and commercialization of therapeutics for serious and life-threatening medical conditions. The company has developed a pipeline of novel drug candidates that target various GPCRs involved in inflammation, fibrosis, and other diseases. Reviva's lead drug candidate, RP5063, is a dopamine-serotonin system targeted drug to enhance brain-derived neurotrophic factor (BDNF) signaling for various CNS diseases, such as schizophrenia, bipolar disorder, and major depressive disorder.
Reviva Pharmaceuticals Holdings was founded in 2005 by Dr. Laxminarayan Bhat, a former Merck scientist, with a vision to develop drugs that target GPCRs to treat various diseases. The company went public in 2020 under the trading symbol "RVPH" on the NASDAQ stock exchange.
Reviva has a world-class team of scientists and advisors with deep expertise in GPCRs and drug discovery. The company has also established several collaborations and partnerships with leading academic institutions and biotech companies to advance its drug discovery efforts.
In conclusion, Reviva Pharmaceuticals Holdings Inc is a biotech company that is dedicated to developing novel small molecule therapeutics that target GPCRs to treat serious and life-threatening medical conditions. The company's focus on developing drugs that target GPCRs has the potential to improve the treatment of several diseases with unmet medical needs.
Company Address: 10080 N. Wolfe Road, Suite SW3-200 Cupertino 95014 CA
Company Phone Number: 501-8881 Stock Exchange / Ticker: NASDAQ RVPH
|
0.09% 